BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12051115)

  • 21. Genistein aglycone: a dual mode of action anti-osteoporotic soy isoflavone rebalancing bone turnover towards bone formation.
    Bitto A; Polito F; Squadrito F; Marini H; D'Anna R; Irrera N; Minutoli L; Granese R; Altavilla D
    Curr Med Chem; 2010; 17(27):3007-18. PubMed ID: 20629630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isoflavone intervention and its impact on bone mineral density in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials.
    Inpan R; Na Takuathung M; Sakuludomkan W; Dukaew N; Teekachunhatean S; Koonrungsesomboon N
    Osteoporos Int; 2024 Mar; 35(3):413-430. PubMed ID: 37875614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can the combination of flaxseed and its lignans with soy and its isoflavones reduce the growth stimulatory effect of soy and its isoflavones on established breast cancer?
    Power KA; Thompson LU
    Mol Nutr Food Res; 2007 Jul; 51(7):845-56. PubMed ID: 17579892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soy and its isoflavones: a review of their effects on bone density.
    Brynin R
    Altern Med Rev; 2002 Aug; 7(4):317-27. PubMed ID: 12197783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biological properties of genistein. A review of in vitro and in vivo data.
    Polkowski K; Mazurek AP
    Acta Pol Pharm; 2000; 57(2):135-55. PubMed ID: 10934794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phytoestrogens and breast cancer: a complex story.
    Helferich WG; Andrade JE; Hoagland MS
    Inflammopharmacology; 2008 Oct; 16(5):219-26. PubMed ID: 18815740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased bone resorption with soy isoflavone supplementation in postmenopausal women.
    Harkness LS; Fiedler K; Sehgal AR; Oravec D; Lerner E
    J Womens Health (Larchmt); 2004 Nov; 13(9):1000-7. PubMed ID: 15665657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functions and action mechanisms of flavonoids genistein and icariin in regulating bone remodeling.
    Ming LG; Chen KM; Xian CJ
    J Cell Physiol; 2013 Mar; 228(3):513-21. PubMed ID: 22777826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the pharmacologic profile of a standardized soy extract in the ovariectomized rat model of menopause: effects on bone, uterus, and lipid profile.
    Gallo D; Zannoni GF; Apollonio P; Martinelli E; Ferlini C; Passetti G; Riva A; Morazzoni P; Bombardelli E; Scambia G
    Menopause; 2005; 12(5):589-600. PubMed ID: 16145313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Soy isoflavones and their bone protective effects.
    Zhang Y; Chen WF; Lai WP; Wong MS
    Inflammopharmacology; 2008 Oct; 16(5):213-5. PubMed ID: 18815742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genistein, a natural phytoestrogen from soy, relieves neuropathic pain following chronic constriction sciatic nerve injury in mice: anti-inflammatory and antioxidant activity.
    Valsecchi AE; Franchi S; Panerai AE; Sacerdote P; Trovato AE; Colleoni M
    J Neurochem; 2008 Oct; 107(1):230-40. PubMed ID: 18691380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro effects of genistein on the synthesis and distribution of glycosaminoglycans/proteoglycans by estrogen receptor-positive and -negative human breast cancer epithelial cells.
    Mitropoulou TN; Tzanakakis GN; Nikitovic D; Tsatsakis A; Karamanos NK
    Anticancer Res; 2002; 22(5):2841-6. PubMed ID: 12530007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of estrogen receptor-beta isoforms by phytoestrogens in breast cancer cells.
    Cappelletti V; Miodini P; Di Fronzo G; Daidone MG
    Int J Oncol; 2006 May; 28(5):1185-91. PubMed ID: 16596234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of genistein on the expression of bone metabolism genes in ovariectomized mice using a cDNA microarray.
    Pie JE; Park JH; Park YH; Ryu YM; Kim KN; Suh SW; Becker KG; Cho-Chung YS; Kim MK
    J Nutr Biochem; 2006 Mar; 17(3):157-64. PubMed ID: 16169203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Isoflavones and calcified tissues].
    Sukmanskiĭ OI
    Usp Fiziol Nauk; 2002; 33(2):83-94. PubMed ID: 12004580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phytoestrogens in the prevention of postmenopausal bone loss.
    Lagari VS; Levis S
    J Clin Densitom; 2013; 16(4):445-9. PubMed ID: 24090647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phytoestrogens activate estrogen receptor beta1 and estrogenic responses in human breast and bone cancer cell lines.
    Chrzan BG; Bradford PG
    Mol Nutr Food Res; 2007 Feb; 51(2):171-7. PubMed ID: 17266178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of estrogenically active substances in diets for sows by an in vitro bioassay supported by HPLC analysis.
    Winter P; Nau H; Lampen A; Kamphues J
    J Anim Physiol Anim Nutr (Berl); 2008 Jun; 92(3):337-44. PubMed ID: 18477315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early induction of LDL receptor gene expression by genistein in DLD-1 colon cancer cell line.
    Caruso MG; Messa C; Orlando A; D'Attoma B; Notarnicola M
    Fitoterapia; 2008 Dec; 79(7-8):524-8. PubMed ID: 18621112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Soy isoflavone intake inhibits bone resorption and stimulates bone formation in menopausal women: meta-analysis of randomized controlled trials.
    Ma DF; Qin LQ; Wang PY; Katoh R
    Eur J Clin Nutr; 2008 Feb; 62(2):155-61. PubMed ID: 17392695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.